Disc Medicine (IRON) Cash & Current Investments (2020 - 2026)

Disc Medicine (IRON) has 7 years of Cash & Current Investments data on file, last reported at $730.2 million in Q1 2026.

• Quarterly Cash & Current Investments rose 5.11% year-over-year to $730.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $730.2 million (up 5.11% YoY) and the FY2025 annual result came in at $791.2 million, up 61.5% from the prior year.
• Cash & Current Investments retreated to $730.2 million in Q1 2026 per IRON's latest filing, from $791.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $791.2 million in Q4 2025 and bottomed at $101.7 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $377.6 million (2023), against an average of $421.9 million.
• The widest annual swing landed in 2022, when Cash & Current Investments sank 35.14%; it then jumped 264.31% in 2023.
• Tracing IRON's Cash & Current Investments over 5 years: stood at $194.6 million in 2022, then jumped by 85.18% to $360.4 million in 2023, then jumped by 35.93% to $489.9 million in 2024, then soared by 61.5% to $791.2 million in 2025, then fell by 7.71% to $730.2 million in 2026.
• Per Business Quant, the three latest IRON Cash & Current Investments figures stand at $730.2 million (Q1 2026), $791.2 million (Q4 2025), and $615.9 million (Q3 2025).

Peer Comparison